Citation Impact
Citing Papers
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
2011
A large fraction of HLA class I ligands are proteasome-generated spliced peptides
2016 Science
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
2005 Standout
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells
2008 StandoutNobel
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
2009 StandoutNobel
Designing CD8+ T cell vaccines: it's not rocket science (yet)
2010
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Dendritic Cells: Translating Innate to Adaptive Immunity
2006 StandoutNobel
Immunoproteasomes
2012
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
2007
Features of the dendritic cell lineage
2010 StandoutNobel
Mechanism and medical implications of mammalian autophagy
2018 Standout
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes
2017
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The PD-1–PD-L pathway in immunological tolerance
2006 StandoutNobel
Hypomorphic Mutation in the Site-1 Protease Mbtps1 Endows Resistance to Persistent Viral Infection in a Cell-Specific Manner
2011 StandoutNobel
The Bacterial Cell Envelope
2010 Standout
Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
2014
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
2005 StandoutNobel
Type I interferons in infectious disease
2015 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Post-Translational Peptide Splicing and T Cell Responses
2017
Deletion of Immunoproteasome Subunits Imprints on the Transcriptome and Has a Broad Impact on Peptides Presented by Major Histocompatibility Complex I molecules
2010
Ins and Outs of Dendritic Cells
2006
Fcγ receptors as regulators of immune responses
2007 Standout
Molecular chaperones in protein folding and proteostasis
2011 StandoutNature
The surprising complexity of signal sequences
2006
Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity
2012
Taking dendritic cells into medicine
2007 StandoutNatureNobel
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
Antigens for cancer immunotherapy
2008
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides
2016
Cancer immunotherapy comes of age
2011 StandoutNature
The regulation of inflammation by interferons and their STATs
2013
Broad action of Hsp90 as a host chaperone required for viral replication
2011
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
2008 Standout
Targeting autophagy in cancer
2017 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Proteasome Activators
2011
Protein interface classification by evolutionary analysis
2012
The Hallmarks of Aging
2013 Standout
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
The secret ally: immunostimulation by anticancer drugs
2012
Molecular and cellular insights into T cell exhaustion
2015 Standout
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
2012
Toll-Like Receptor Signaling Pathways
2014 Standout
The role of ubiquitylation in immune defence and pathogen evasion
2011
Molecular Architecture and Assembly of the Eukaryotic Proteasome
2013
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
2010 Nature
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA
2006
SWISS-MODEL: homology modelling of protein structures and complexes
2018 Standout
The CD8+T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old Virus
2007
Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3/4A Cleavage and Replication
2016 StandoutNobel
Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1
2016 StandoutNobel
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
2015
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
HIV-1 Selectively Infects a Subset of Nonmaturing BDCA1-Positive Dendritic Cells in Human Blood
2006 StandoutNobel
Different affinity windows for virus and cancer‐specific T ‐cell receptors: Implications for therapeutic strategies
2012
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors
2007 StandoutNobel
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Mass Spectrometry Analysis and Quantitation of Peptides Presented on the MHC II Molecules of Mouse Spleen Dendritic Cells
2011 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
Palladium‐Catalyzed Fluorosulfonylvinylation of Organic Iodides
2017 StandoutNobel
Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b −/− Pdcd1 −/− mice
2005 StandoutNobel
Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3)
2011 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Proteasomal and Autophagic Degradation Systems
2017
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Cell entry by human pathogenic arenaviruses
2008
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Nucleoprotein‐specific nonneutralizing antibodies speed up LCMV elimination independently of complement and F cγR
2013
Works of Michael Basler being referenced
Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome
2010
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
2014
Long-lived Signal Peptide of Lymphocytic Choriomeningitis Virus Glycoprotein pGP-C
2003
Proteasomes in immune cells: more than peptide producers?
2009
Immuno- and Constitutive Proteasomes Do Not Differ in Their Abilities to Degrade Ubiquitinated Proteins
2013
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
2009
The immunoproteasome in antigen processing and other immunological functions
2012
Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity
2012
The immunoproteasome: a novel drug target for autoimmune diseases.
2015
Immunoproteasome Subunit LMP7 Deficiency and Inhibition Suppresses Th1 and Th17 but Enhances Regulatory T Cell Differentiation
2012
Cross-Presentation of the Long-Lived Lymphocytic Choriomeningitis Virus Nucleoprotein Does Not Require Neosynthesis and Is Enhanced via Heat Shock Proteins
2005
Immunodominance of an Antiviral Cytotoxic T Cell Response Is Shaped by the Kinetics of Viral Protein Expression
2003
The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection
2009
An Altered T Cell Repertoire in MECL-1-Deficient Mice
2006
Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus
2004
The Antiviral Immune Response in Mice Devoid of Immunoproteasome Activity
2011